triethylenemelamine has been researched along with Pain, Chronic in 1 studies
Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Konno, SI | 1 |
| Alev, L | 1 |
| Oda, N | 1 |
| Ochiai, T | 1 |
| Enomoto, H | 1 |
1 trial available for triethylenemelamine and Pain, Chronic
| Article | Year |
|---|---|
An Open-Label, 52-Week, Phase III Trial of Duloxetine in Japanese Patients with Chronic Low Back Pain.
Topics: Adult; Aged; Analgesics; Chronic Pain; Constipation; Duloxetine Hydrochloride; Female; Humans; Japan | 2019 |